Hi there,

For nearly 30 years, Democracy Now! has gone to where the silence is. Our reporting provides news you can’t find anywhere else and helps maintain an informed public, which is critical for a functioning democracy. Thanks to a group of generous donors, our TRIPLE MATCH has been extended through TONIGHT ONLY, which means your $15 gift is worth $45. Please donate today, so we can keep amplifying voices that refuse to be silent. Every dollar makes a difference. Thank you so much!

Democracy Now!
Amy Goodman

Non-commercial news needs your support.

We rely on contributions from you, our viewers and listeners to do our work. If you visit us daily or weekly or even just once a month, now is a great time to make your monthly contribution.

Please do your part today.

Donate

Human Rights & Public Health Groups Blast WTO Deal on COVID Patents

HeadlineJun 17, 2022

The World Trade Organization has agreed to temporarily waive some intellectual property rights on COVID vaccines, but no agreement was reached on lifting patent monopolies on COVID treatments and tests. Hundreds of international organizations, including Oxfam and Amnesty International, criticized the final deal, saying it will make it harder for developing countries to respond to the pandemic. This is Nick Dearden, director of Global Justice Now.

Nick Dearden: “What we’ve got from the World Trade Organization this morning is a poor excuse for a waiver. It is not what we’ve been calling for for the last 18 months. And the fault for that lies with European governments, particularly Britain, Switzerland and Germany. So we’re not happy about that. But there’s one thing we can bank from this: It really is proof that the Big Pharma monopoly system did not help deal with the COVID-19 pandemic and did not help deal with it equitably, most importantly. It drove vaccine inequality.”

The original content of this program is licensed under a Creative Commons Attribution-Noncommercial-No Derivative Works 3.0 United States License. Please attribute legal copies of this work to democracynow.org. Some of the work(s) that this program incorporates, however, may be separately licensed. For further information or additional permissions, contact us.

Non-commercial news needs your support

We rely on contributions from our viewers and listeners to do our work.
Please do your part today.
Make a donation
Top